Physician profile
Eric A Marvin
NPI 1407016082
$11,976.45
in general payments reported to CMS, 2019-2025
12 companies · $174 in 2025
The $174 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $339 · 2020: $8,142 · 2021: $114 · 2022: $1,992 · 2023: $901 · 2024: $314 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,388.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $9,773.15 | 2020-2022 | |
| Depuy Synthes Sales INC. | $988.55 | 2020-2025 | Conduit, Trumatch, Synthecel |
| Medtronic, INC. | $337.77 | 2023-2025 | Intellis Adaptivestim, Solitaire X, Mazor X System |
| Medtronic USA, INC. | $267.38 | 2019 | |
| Integra Lifesciences Corporation | $203.36 | 2019-2023 | Duraseal Exact Spinal Sealant System, Codman Certas, Cusa Clarity |
| Stryker Corporation | $163.56 | 2022 | |
| Gt Medical Technologies, INC | $94.98 | 2023 | Gammatile |
| Nevro Corp. | $49.75 | 2021 | |
| Boston Scientific Corporation | $44.00 | 2023 | Wavewriter Alpha Prime 16 |
| Biocomposites INC | $37.87 | 2024 | |
| Si-Bone, INC. | $16.08 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Marvin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.